These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31706667)

  • 1. Structure-activity relationship of 4-azaindole-2-piperidine derivatives as agents against Trypanosoma cruzi.
    Koovits PJ; Dessoy MA; Matheeussen A; Maes L; Caljon G; Mowbray CE; Kratz JM; Dias LC
    Bioorg Med Chem Lett; 2020 Jan; 30(1):126779. PubMed ID: 31706667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Design, and Structure-Activity Relationship of a Benzenesulfonylpiperazine Series against Trypanosoma cruzi.
    Cassiano Martinho AC; de Melo Resende D; Landin ES; Dit Lapierre TJWJ; Bernardes TCD; Martins LC; Ferreira RS; Murta SMF; de Oliveira Rezende Júnior C
    ChemMedChem; 2022 Oct; 17(19):e202200211. PubMed ID: 35993440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new chemotype with promise against Trypanosoma cruzi.
    Wang X; Cal M; Kaiser M; Buckner FS; Lepesheva GI; Sanford AG; Wallick AI; Davis PH; Vennerstrom JL
    Bioorg Med Chem Lett; 2020 Jan; 30(1):126778. PubMed ID: 31706668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening.
    Melo-Filho CC; Braga RC; Muratov EN; Franco CH; Moraes CB; Freitas-Junior LH; Andrade CH
    Eur J Med Chem; 2019 Feb; 163():649-659. PubMed ID: 30562700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current advances in drug discovery for Chagas disease.
    Scarim CB; Jornada DH; Chelucci RC; de Almeida L; Dos Santos JL; Chung MC
    Eur J Med Chem; 2018 Jul; 155():824-838. PubMed ID: 30033393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease.
    Riley J; Brand S; Voice M; Caballero I; Calvo D; Read KD
    PLoS Negl Trop Dis; 2015 Sep; 9(9):e0004014. PubMed ID: 26394211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease.
    Gaspar L; Coron RP; KongThoo Lin P; Costa DM; Perez-Cabezas B; Tavares J; Roura-Ferrer M; Ramos I; Ronin C; Major LL; Ciesielski F; Pemberton IK; MacDougall J; Ciapetti P; Smith TK; Cordeiro-da-Silva A
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006180. PubMed ID: 29357372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death.
    da Silva EB; Oliveira E Silva DA; Oliveira AR; da Silva Mendes CH; Dos Santos TA; da Silva AC; de Castro MC; Ferreira RS; Moreira DR; Cardoso MV; de Simone CA; Pereira VR; Leite AC
    Eur J Med Chem; 2017 Apr; 130():39-50. PubMed ID: 28242550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting Pyrazolo[3,4-
    Bouton J; Ferreira de Almeida Fiuza L; Cardoso Santos C; Mazzarella MA; Soeiro MNC; Maes L; Karalic I; Caljon G; Van Calenbergh S
    J Med Chem; 2021 Apr; 64(7):4206-4238. PubMed ID: 33784107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi.
    Ribeiro TS; Freire-de-Lima L; Previato JO; Mendonça-Previato L; Heise N; de Lima ME
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3555-8. PubMed ID: 15177472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chagas Disease Drug Discovery: Multiparametric Lead Optimization against
    Fleau C; Padilla A; Miguel-Siles J; Quesada-Campos MT; Saiz-Nicolas I; Cotillo I; Cantizani Perez J; Tarleton RL; Marco M; Courtemanche G
    J Med Chem; 2019 Nov; 62(22):10362-10375. PubMed ID: 31657555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
    Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
    Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant metabolites active against Trypanosoma cruzi.
    Sepúlveda-Boza S; Cassels BK
    Planta Med; 1996 Apr; 62(2):98-105. PubMed ID: 8657759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialkylimidazole inhibitors of Trypanosoma cruzi sterol 14α-demethylase as anti-Chagas disease agents.
    Suryadevara PK; Racherla KK; Olepu S; Norcross NR; Tatipaka HB; Arif JA; Planer JD; Lepesheva GI; Verlinde CL; Buckner FS; Gelb MH
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6492-9. PubMed ID: 24120539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitrypanosomal and antioxidant properties of 4-hydroxycoumarins derivatives.
    Pérez-Cruz F; Serra S; Delogu G; Lapier M; Maya JD; Olea-Azar C; Santana L; Uriarte E
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5569-73. PubMed ID: 22832320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirubin derivatives are potent and selective anti-Trypanosoma cruzi agents.
    Efstathiou A; Meira CS; Gaboriaud-Kolar N; Bastos TM; Rocha VPC; Vougogiannopoulou K; Skaltsounis AL; Smirlis D; Soares MBP
    Virulence; 2018; 9(1):1658-1668. PubMed ID: 30387370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chagas Disease: A Solvable Problem, Ignored.
    Tarleton RL
    Trends Mol Med; 2016 Oct; 22(10):835-838. PubMed ID: 27523778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, physicochemical properties of allopurinol derivatives and their biological activity against Trypanosoma cruzi.
    Raviolo MA; Solana ME; Novoa MM; Gualdesi MS; Alba-Soto CD; Briñón MC
    Eur J Med Chem; 2013 Nov; 69():455-64. PubMed ID: 24090917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semisynthesis of new aphidicolin derivatives with high activity against Trypanosoma cruzi.
    Santos GB; Krogh R; Magalhaes LG; Andricopulo AD; Pupo MT; Emery FS
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1205-8. PubMed ID: 26810263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.